NOVARTIS has inked a Memorandum of Understanding (MoU) with the Hunter Medical Research Institute to work more closely together on healthcare research projects.
The collaboration is being supported by the University of Newcastle, with the three parties organisations set to explore opportunities to advance medical science and improve patient care.
Novartis Country President Australia and New Zealand, Matt Zeller, said the MoU would open opportunities to expand research into fields such as cardiovascular disease.
"This partnership allows our HMRI affiliated researchers, University of Newcastle experts and clinicians to deliver life-changing innovations at a speed unmatched in Australia, if not the world," said HMRI's Institute Director and CEO, Professor Frances Kay-Lambkin.
The above article was sent to subscribers in Pharmacy Daily's issue from 20 Feb 25
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 20 Feb 25
